Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Stanford Lymphoma Program is comprised of a dedicated core of individuals who have pioneered significant advances in the treatment of lymphoma. Members of this team are routinely recognized and awarded for their contributions to the treatment of lymphoma for both adults and children.
After struggling to treat a persistent rash, Paul Raffer learned it was a rare blood cancer called mycosis fungoides. Individualized treatments saved his life.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.